Therapeutic leukocytapheresis for inflammatory bowel disease
- 1 October 2007
- journal article
- review article
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 37 (2) , 191-200
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Demonstration of Low-Regulatory CD25High+CD4+ and High-Pro-inflammatory CD28−CD4+ T-Cell Subsets in Patients with Ulcerative Colitis: Modified by Selective Granulocyte and Monocyte Adsorption ApheresisDigestive Diseases and Sciences, 2007
- Adacolumn Selective Leukocyte Adsorption Apheresis in Patients with Active Ulcerative Colitis: Clinical Efficacy, Effects on Plasma IL-8, and Expression of Toll-like Receptor 2 on GranulocytesDigestive Diseases and Sciences, 2007
- A Retrospective Search for Predictors of Clinical Response to Selective Granulocyte and Monocyte Apheresis in Patients With Ulcerative ColitisDigestive Diseases and Sciences, 2006
- Adsorptive granulocyte and monocyte apheresis for refractory Crohn?s disease: an open multicenter prospective studyJournal of Gastroenterology, 2004
- Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug AdministrationArthritis & Rheumatism, 2002
- Crohn's diseaseThe Lancet, 2002
- The production of cytokines by polymorphonuclear neutrophilsImmunology Today, 1995
- Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence ofin vivoactivation in active diseaseClinical and Experimental Immunology, 1991
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- SulfasalazineDigestive Diseases and Sciences, 1983